LD50 oral mice = 1460 mg/kg, LD50 oral rats = 1780 mg/kg. Spasm or closing of eyelids, nausea, vomiting, cardiac arrhythmias, involuntary movements of the body including the face, tongue, arms, hand, head, and upper body; hypotension, haemolytic anaemia, urinary retention, duodenal ulcer, sialorrhea, ataxia, abdominal pain, dry mouth, nightmares, tachypnoea, bruxism, confusion, and insomnia.
One of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Hyaluronidase (ovine) | The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Dopamine. |
| Hyaluronidase (human recombinant) | The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Dopamine. |
| Hyaluronidase | The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Dopamine. |
| Valsartan | Dopamine may decrease the antihypertensive activities of Valsartan. |
| Ramipril | Dopamine may decrease the antihypertensive activities of Ramipril. |
| Esmolol | Dopamine may decrease the antihypertensive activities of Esmolol. |
| Betaxolol | Dopamine may decrease the antihypertensive activities of Betaxolol. |
| Remikiren | Dopamine may decrease the antihypertensive activities of Remikiren. |
| Guanadrel | Dopamine may decrease the antihypertensive activities of Guanadrel. |
| Olmesartan | Dopamine may decrease the antihypertensive activities of Olmesartan. |
| Atenolol | Dopamine may decrease the antihypertensive activities of Atenolol. |
| Diltiazem | Dopamine may decrease the antihypertensive activities of Diltiazem. |
| Minoxidil | Dopamine may decrease the antihypertensive activities of Minoxidil. |
| Treprostinil | Dopamine may decrease the antihypertensive activities of Treprostinil. |
| Amlodipine | Dopamine may decrease the antihypertensive activities of Amlodipine. |
| Nimodipine | Dopamine may decrease the antihypertensive activities of Nimodipine. |
| Trandolapril | Dopamine may decrease the antihypertensive activities of Trandolapril. |
| Lercanidipine | Dopamine may decrease the antihypertensive activities of Lercanidipine. |
| Benazepril | Dopamine may decrease the antihypertensive activities of Benazepril. |
| Bosentan | Dopamine may decrease the antihypertensive activities of Bosentan. |
| Enalapril | Dopamine may decrease the antihypertensive activities of Enalapril. |
| Candoxatril | Dopamine may decrease the antihypertensive activities of Candoxatril. |
| Nicardipine | Dopamine may decrease the antihypertensive activities of Nicardipine. |
| Losartan | Dopamine may decrease the antihypertensive activities of Losartan. |
| Moexipril | Dopamine may decrease the antihypertensive activities of Moexipril. |
| Nitroglycerin | Dopamine may decrease the antihypertensive activities of Nitroglycerin. |
| Metyrosine | Dopamine may decrease the antihypertensive activities of Metyrosine. |
| Cryptenamine | Dopamine may decrease the antihypertensive activities of Cryptenamine. |
| Candesartan cilexetil | Dopamine may decrease the antihypertensive activities of Candesartan cilexetil. |
| Alprenolol | Dopamine may decrease the antihypertensive activities of Alprenolol. |
| Eprosartan | Dopamine may decrease the antihypertensive activities of Eprosartan. |
| Quinapril | Dopamine may decrease the antihypertensive activities of Quinapril. |
| Telmisartan | Dopamine may decrease the antihypertensive activities of Telmisartan. |
| Felodipine | Dopamine may decrease the antihypertensive activities of Felodipine. |
| Irbesartan | Dopamine may decrease the antihypertensive activities of Irbesartan. |
| Nitrendipine | Dopamine may decrease the antihypertensive activities of Nitrendipine. |
| Deserpidine | Dopamine may decrease the antihypertensive activities of Deserpidine. |
| Pentolinium | Dopamine may decrease the antihypertensive activities of Pentolinium. |
| Trimethaphan | Dopamine may decrease the antihypertensive activities of Trimethaphan. |
| Carvedilol | Dopamine may decrease the antihypertensive activities of Carvedilol. |
| Bretylium | Dopamine may decrease the antihypertensive activities of Bretylium. |
| Terazosin | Dopamine may decrease the antihypertensive activities of Terazosin. |
| Captopril | Dopamine may decrease the antihypertensive activities of Captopril. |
| Bepridil | Dopamine may decrease the antihypertensive activities of Bepridil. |
| Bevantolol | Dopamine may decrease the antihypertensive activities of Bevantolol. |
| Practolol | Dopamine may decrease the antihypertensive activities of Practolol. |
| Cilazapril | Dopamine may decrease the antihypertensive activities of Cilazapril. |
| Saprisartan | Dopamine may decrease the antihypertensive activities of Saprisartan. |
| Spirapril | Dopamine may decrease the antihypertensive activities of Spirapril. |
| Mibefradil | Dopamine may decrease the antihypertensive activities of Mibefradil. |
| Dexpropranolol | Dopamine may decrease the antihypertensive activities of Dexpropranolol. |
| Debrisoquine | Dopamine may decrease the antihypertensive activities of Debrisoquine. |
| Nebivolol | Dopamine may decrease the antihypertensive activities of Nebivolol. |
| Sitaxentan | Dopamine may decrease the antihypertensive activities of Sitaxentan. |
| Ambrisentan | Dopamine may decrease the antihypertensive activities of Ambrisentan. |
| Diethylnorspermine | Dopamine may decrease the antihypertensive activities of Diethylnorspermine. |
| Nilvadipine | Dopamine may decrease the antihypertensive activities of Nilvadipine. |
| Pinacidil | Dopamine may decrease the antihypertensive activities of Pinacidil. |
| Bupranolol | Dopamine may decrease the antihypertensive activities of Bupranolol. |
| Temocapril | Dopamine may decrease the antihypertensive activities of Temocapril. |
| Riociguat | Dopamine may decrease the antihypertensive activities of Riociguat. |
| Indenolol | Dopamine may decrease the antihypertensive activities of Indenolol. |
| Hexamethonium | Dopamine may decrease the antihypertensive activities of Hexamethonium. |
| Aliskiren | Dopamine may decrease the antihypertensive activities of Aliskiren. |
| Trimazosin | Dopamine may decrease the antihypertensive activities of Trimazosin. |
| Lacidipine | Dopamine may decrease the antihypertensive activities of Lacidipine. |
| Manidipine | Dopamine may decrease the antihypertensive activities of Manidipine. |
| Niguldipine | Dopamine may decrease the antihypertensive activities of Niguldipine. |
| Rauwolfia serpentina root | Dopamine may decrease the antihypertensive activities of Rauwolfia serpentina root. |
| Selexipag | Dopamine may decrease the antihypertensive activities of Selexipag. |
| Angiotensin 1-7 | Dopamine may decrease the antihypertensive activities of Angiotensin 1-7. |
| Talinolol | Dopamine may decrease the antihypertensive activities of Talinolol. |
| Imidapril | Dopamine may decrease the antihypertensive activities of Imidapril. |
| BQ-123 | Dopamine may decrease the antihypertensive activities of BQ-123. |
| Tetrahydropalmatine | Dopamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Landiolol | Dopamine may decrease the antihypertensive activities of Landiolol. |
| Dihydralazine | Dopamine may decrease the antihypertensive activities of Dihydralazine. |
| Zofenopril | Dopamine may decrease the antihypertensive activities of Zofenopril. |
| Guanoxan | Dopamine may decrease the antihypertensive activities of Guanoxan. |
| Delapril | Dopamine may decrease the antihypertensive activities of Delapril. |
| Vincamine | Dopamine may decrease the antihypertensive activities of Vincamine. |
| Linsidomine | Dopamine may decrease the antihypertensive activities of Linsidomine. |
| Guanoxabenz | Dopamine may decrease the antihypertensive activities of Guanoxabenz. |
| Tolonidine | Dopamine may decrease the antihypertensive activities of Tolonidine. |
| Endralazine | Dopamine may decrease the antihypertensive activities of Endralazine. |
| Esatenolol | Dopamine may decrease the antihypertensive activities of Esatenolol. |
| Cadralazine | Dopamine may decrease the antihypertensive activities of Cadralazine. |
| Cloranolol | Dopamine may decrease the antihypertensive activities of Cloranolol. |
| Bietaserpine | Dopamine may decrease the antihypertensive activities of Bietaserpine. |
| Guanazodine | Dopamine may decrease the antihypertensive activities of Guanazodine. |
| Methoserpidine | Dopamine may decrease the antihypertensive activities of Methoserpidine. |
| Guanoclor | Dopamine may decrease the antihypertensive activities of Guanoclor. |
| Candesartan | Dopamine may decrease the antihypertensive activities of Candesartan. |
| Dexniguldipine | Dopamine may decrease the antihypertensive activities of Dexniguldipine. |
| Tocopherylquinone | Dopamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Benazeprilat | Dopamine may decrease the antihypertensive activities of Benazeprilat. |
| Fosinoprilat | Dopamine may decrease the antihypertensive activities of Fosinoprilat. |
| Ramiprilat | Dopamine may decrease the antihypertensive activities of Ramiprilat. |
| Perindoprilat | Dopamine may decrease the antihypertensive activities of Perindoprilat. |
| Quinaprilat | Dopamine may decrease the antihypertensive activities of Quinaprilat. |